Skip to content
10-Q

Quarterly Report

AEOLUS PHARMACEUTICALS, INC.

0001102624-16-003292

← back to feed
Filed
Aug 15, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Aug 15, 2016 152.09M sh
Stockholders Equity Q3 2016 · Jun 30, 2016 $4.19M
Stockholders Equity Q3 2016 · Sep 30, 2015 −$845K
Current Liabilities Q3 2016 · Jun 30, 2016 $688K
Current Liabilities Q3 2016 · Sep 30, 2015 $2.62M
Total Liabilities Q3 2016 · Jun 30, 2016 $688K
Total Liabilities Q3 2016 · Sep 30, 2015 $2.62M
Current Assets Q3 2016 · Jun 30, 2016 $4.84M
Current Assets Q3 2016 · Sep 30, 2015 $1.75M
Total Assets Q3 2016 · Jun 30, 2016 $4.87M
Total Assets Q3 2016 · Sep 30, 2015 $1.78M
Shares Diluted Q3 2016 · Jun 30, 2015 135.9K sh
Shares Diluted Q3 2016 · Jun 30, 2015 135.87K sh
Operating Cash Flow Q3 2016 · Jun 30, 2015 −$1.12M
Cash And Equivalents Q3 2016 · Jun 30, 2015 $416K
Cash And Equivalents Q3 2016 · Sep 30, 2014 $1.52M
Eps Diluted Q3 2016 · Jun 30, 2015 −$0.01
Eps Diluted Q3 2016 · Jun 30, 2015 −$0.02
Eps Basic Q3 2016 · Jun 30, 2015 −$0.01
Eps Basic Q3 2016 · Jun 30, 2015 −$0.02
Sga Expense Q3 2016 · Jun 30, 2015 $578K
Sga Expense Q3 2016 · Jun 30, 2015 $1.83M
Rd Expense Q3 2016 · Jun 30, 2015 $269K
Rd Expense Q3 2016 · Jun 30, 2015 $2.54M
Net Income Q3 2016 · Jun 30, 2015 −$784K
Net Income Q3 2016 · Jun 30, 2015 −$2.19M
Operating Income Q3 2016 · Jun 30, 2015 −$784K
Operating Income Q3 2016 · Jun 30, 2015 −$2.19M